GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Interpharm Holdings Inc (GREY:IPAH) » Definitions » Cyclically Adjusted Price-to-FCF

Interpharm Holdings (Interpharm Holdings) Cyclically Adjusted Price-to-FCF : (As of Jun. 16, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Interpharm Holdings Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Interpharm Holdings Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Interpharm Holdings's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interpharm Holdings Cyclically Adjusted Price-to-FCF Chart

Interpharm Holdings Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Interpharm Holdings Quarterly Data
Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Interpharm Holdings's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Interpharm Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interpharm Holdings's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Interpharm Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Interpharm Holdings's Cyclically Adjusted Price-to-FCF falls into.



Interpharm Holdings Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Interpharm Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2007 is calculated as:

For example, Interpharm Holdings's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2007 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2007 (Change)*Current CPI (Dec. 2007)
=-0.103/88.6164*88.6164
=-0.103

Current CPI (Dec. 2007) = 88.6164.

Interpharm Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
199803 -0.669 68.434 -0.866
199806 0.798 68.771 1.028
199809 0.375 69.025 0.481
199812 0.885 69.151 1.134
199903 -0.631 69.615 -0.803
199906 -0.521 70.122 -0.658
199909 0.028 70.839 0.035
199912 0.027 71.008 0.034
200003 -0.154 72.231 -0.189
200006 -0.132 72.737 -0.161
200009 0.206 73.286 0.249
200012 -0.001 73.413 -0.001
200103 -0.047 74.341 -0.056
200106 0.040 75.100 0.047
200109 -0.097 75.227 -0.114
200112 0.288 74.552 0.342
200203 -0.253 75.438 -0.297
200206 0.053 75.902 0.062
200209 -0.006 76.366 -0.007
200212 0.016 76.324 0.019
200303 -0.070 77.716 -0.080
200306 0.018 77.505 0.021
200309 -0.030 78.138 -0.034
200312 -0.001 77.758 -0.001
200403 -0.008 79.066 -0.009
200406 0.005 80.037 0.006
200409 0.022 80.121 0.024
200412 -0.061 80.290 -0.067
200503 -0.075 81.555 -0.081
200506 -0.214 82.062 -0.231
200509 -0.032 83.876 -0.034
200512 0.055 83.032 0.059
200603 -0.108 84.298 -0.114
200606 -0.107 85.606 -0.111
200609 0.002 85.606 0.002
200612 -0.069 85.142 -0.072
200703 -0.114 86.640 -0.117
200706 -0.155 87.906 -0.156
200709 -0.075 87.964 -0.076
200712 -0.103 88.616 -0.103

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Interpharm Holdings  (GREY:IPAH) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Interpharm Holdings Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Interpharm Holdings's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Interpharm Holdings (Interpharm Holdings) Business Description

Traded in Other Exchanges
N/A
Address
75 Adams Avenue, Hauppague, NY, USA, 11788
Website
Interpharm Holdings Inc manufactures generic and over-the-counter medications. The company also pursues the development of other generic drugs in broad categories.

Interpharm Holdings (Interpharm Holdings) Headlines

No Headlines